The proteinaceous biofilm of Gardnerella vaginalis enables a novel enzymatic therapy for bacterial vaginosis

Key Points

• Enzymatic therapy shows promise for treating bacterial vaginosis by targeting the proteinaceous biofilm.
• The study highlights how the presence of gardnerella vaginalis can impact the effectiveness of medications.
• Assessment across various conditions elucidates the role of biofilms in bacterial vaginosis treatments.
• Further research may enable new therapeutic strategies against bacterial infections related to biofilms.